Confo Therapeutics

📍 Zwijnaarde, Belgium🗓 Founded 2015👥 62 employees💰 Last funded Jun 2020
Biotechnology🌐 confotherapeutics.com
Website LinkedIn
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium. For more information: www.confotherapeutics.com
8
Total investors
3
Early stage
5
Mid stage
0
Late stage
2015
Founded

Investors

8 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
5
Netherlands
2
United States
1
Investor activity2015–2020 · investors recorded per year
2015220161201812019120203
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Confo Therapeutics?
Confo Therapeutics has 8 investors on record on gritt.io, including 3 early-stage backers, 5 mid-stage.
When did Confo Therapeutics last raise funding?
The most recent investment in Confo Therapeutics recorded on gritt.io was in June 2020.
When was Confo Therapeutics founded?
Confo Therapeutics was founded in 2015.
What industry is Confo Therapeutics in?
Confo Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Confo Therapeutics based?
Confo Therapeutics is headquartered in Zwijnaarde, Belgium.